MEPIRAPIM
外观
![]() | |
法律规范状态 | |
---|---|
法律规范 |
|
识别信息 | |
| |
CAS号 | 2365542-29-4 |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
化学信息 | |
化学式 | C19H27N3O |
摩尔质量 | 313.45 g·mol−1 |
3D模型(JSmol) | |
| |
|
MEPIRAPIM,化学名(4-甲基哌嗪-1-基)(1-戊基吲哚-3-基)甲酮(英语:(4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone),分子式C19H27N3O,是JWH-018的结构类似物,其中4-甲基哌嗪基团替代了萘基团[1],能作为大麻素,2013年在日本首次发现,一同检出的还有FUBIMINA[2]。
参考文献
[编辑]- ^ MEPIRAPIM. Cayman Chemical. [23 June 2015].
- ^ Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products. Forensic Toxicology. January 2014, 32 (1): 105–115. S2CID 32599561. doi:10.1007/s11419-013-0217-2.